by Tina Koutouleas | Oct 4, 2019 | Life Science, Pharma
We take a deep dive into new and existing #breakthrough technologies which have the potential to cure cancer patients. We kick off the month by delving into #Biosimilars. Biosimilars aren’t “new” drugs, but they are significantly changing the landscape of...
by Tina Koutouleas | May 9, 2019 | Biotech, Entrepreneurship, Life Science, Pharma
Dr. Rafel Simó Vicens has been a part of the REBBLS CORE group since August 2017. He has recently defended his Ph.D which investigated the pharmacological inhibition of KCa2 channels as a new therapeutic target for the treatment of atrial fibrillation. We asked him...
by Tina Koutouleas | Feb 27, 2019 | Biotech, Entrepreneurship, Innovation, Life Science
A personal commentary by Tina Koutouleas What is Biohacking? Biohacking is anything that “hacks” i.e. improves our natural biology from microbe to human by people outside of the usual bounds of research. What comes to mind when you hear the word biohacking? If you had...
by master | Oct 5, 2018 | Biotech, Discovery, Innovation, Life Science, REBBLog
Photo by Manuel Barroso Parejo on Unsplash Back in June, the EU court came out with its highly anticipated ruling on gene-edited organisms. You might have heard of gene-editing, as specifically the CRISPR technology has been making headlines, not only due to its huge...
